Thursday, 17 Aug 2017

PsA/SpA

Datesort ascending Type Title Save
13 Oct 2016 Blog If You See Something, Say Something
12 Oct 2016 Social Norwegian HUNT study of shows no increased risk offracture among 2804 self reported Psoriasis patients. https://t.co/PHNMUac27A
11 Oct 2016 News First Degree Relatives and the Risk of Spondyloarthritis
10 Oct 2016 Social RT @RheumNow: If you spot a stranger w/ classic habitus & gait of Ankylosing spondylitis - do you approach & tell them the dx or do you kee…
07 Oct 2016 Social Am I wrong?Otezla warnings overstate risk of depression % wt loss; yet understate diarrhea 9% & D/C for diarrhea <2% https://t.co/UwFi8b6txr
06 Oct 2016 Social Milestones in the drug development of anti-IL17, Secukinumab for rheumatologyy https://t.co/H17tWhuxUz https://t.co/exGS3ELdbe
03 Oct 2016 News Anti-IL-23 Guselkumab Beats Adalimumab in Severe Psoriasis
29 Sep 2016 Social Taiwan: HIV population higher risk for Sjögrens(SIR=1.64), psoriasis(2.05), SLE (2.59), AIHA (35.06), Uveitis (2.50) https://t.co/qsgODbKKxW
19 Sep 2016 Social Why I Luv Rheum: Sitting next to me, 1 swollen PIP w/ onycholysis= I know its Psoriatic Arthritis I can help!! #RDAM https://t.co/0HI7JQTkUB
15 Sep 2016 Social RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #…
14 Sep 2016 News Adalimumab Lowers Risk of Uveitis Flares in Visual I Study
27 Aug 2016 Social Ixekizumab (Taltz), IL-17 inhibitor, better than Placebo, but same as Humira @24wks in treating psoriatic arthritis https://t.co/vFqF31oMLZ
24 Aug 2016 News Adalimumab Controls Non-Infectious Uveitis in VISUAL II Study
23 Aug 2016 Social Structural progression is low (~5%) in early SpA; Sacroiliitis risk factors were B27, smoking & MRI SI inflammation https://t.co/MWsxlbb6lt
23 Aug 2016 Social Confusing names: Spondylolysis, Spondylolisthesis, Spondylitis & Spondylosis explained. https://t.co/EfHzzsyENY
19 Aug 2016 Social Ankylosing spondylitis has 14% incr risk of cancer; GI tract (RR 1.20); M.myelomas (RR 1.92); lymphoma (RR 1.32) https://t.co/ggQyT7kyw3
16 Aug 2016 News Fewer Psoriasis Patients Satisfied with Current Treatments
05 Aug 2016 News Severe, Refractory Psoriasis in HIV-Positive Patients: Are TNF Inhibitors a Solution?
04 Aug 2016 News RAPID3: An Effective Assessment Tool in Spondyloarthritis
25 Jul 2016 News Novel Rise of Combined Dermatology-Rheumatology Clinics